Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Uniqure N.V. (QURE)

Uniqure N.V. (QURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 274,302
  • Shares Outstanding, K 48,549
  • Annual Sales, $ 15,840 K
  • Annual Income, $ -308,480 K
  • 60-Month Beta 0.95
  • Price/Sales 16.66
  • Price/Cash Flow N/A
  • Price/Book 2.72
Trade QURE with:

Options Overview Details

View History
  • Implied Volatility 61.63% ( -42.57%)
  • Historical Volatility 90.65%
  • IV Percentile 16%
  • IV Rank 26.10%
  • IV High 204.23% on 11/13/23
  • IV Low 11.27% on 05/07/24
  • Put/Call Vol Ratio 0.07
  • Today's Volume 357
  • Volume Avg (30-Day) 536
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 37,759
  • Open Int (30-Day) 34,277

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -1.12
  • Number of Estimates 6
  • High Estimate -0.97
  • Low Estimate -1.32
  • Prior Year -1.88
  • Growth Rate Est. (year over year) +40.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.45 +26.97%
on 10/03/24
6.15 -8.13%
on 10/08/24
+0.18 (+3.29%)
since 09/11/24
3-Month
4.45 +26.97%
on 10/03/24
10.02 -43.58%
on 07/17/24
-3.26 (-36.59%)
since 07/11/24
52-Week
3.73 +51.47%
on 07/05/24
11.35 -50.22%
on 07/10/24
-1.26 (-18.23%)
since 10/11/23

Most Recent Stories

More News
UniQure: Q2 Earnings Snapshot

UniQure: Q2 Earnings Snapshot

QURE : 5.65 (+4.24%)
UniQure: Q1 Earnings Snapshot

UniQure: Q1 Earnings Snapshot

QURE : 5.65 (+4.24%)
UniQure: Q3 Earnings Snapshot

UniQure: Q3 Earnings Snapshot

QURE : 5.65 (+4.24%)
Why Shares of uniQure Are Up Thursday

The company announced a reorganization that included layoffs.

QURE : 5.65 (+4.24%)
Why Shares of uniQure Are Dropping Tuesday

The company is facing being delisted from the S&P 600 Index.

QURE : 5.65 (+4.24%)
UniQure: Q2 Earnings Snapshot

UniQure: Q2 Earnings Snapshot

QURE : 5.65 (+4.24%)
Why uniQure Stock Cratered This Week

An interim analysis for the company's Huntington's disease gene therapy wasn't a hit with investors.

QURE : 5.65 (+4.24%)
Why uniQure Stock Is Crashing Today

Investors are focusing on the negative parts of the biotech company's interim results.

QURE : 5.65 (+4.24%)
Stocks Rise on Optimism About the Debt Ceiling

The S&P 500 Index ( $SPX ) ( SPY ) is up +0.09%, the Dow Jones Industrials Index ( $DOWI ) ( DIA ) is up +0.01%, and the Nasdaq 100 Index ( $IUXX ) ( QQQ ) is up +0.35%. U.S. stock index futures this morning...

ESZ24 : 5,859.75s (+0.53%)
NQZ24 : 20,450.00s (+0.10%)
SRPT : 124.51 (+1.72%)
MARA : 16.08 (+5.58%)
RIOT : 8.41 (+8.66%)
COIN : 176.38 (+7.37%)
MSTR : 212.59 (+15.95%)
SHAK : 107.81 (-1.90%)
QURE : 5.65 (+4.24%)
META : 589.95 (+1.05%)
MNDY : 289.56 (+2.46%)
ALB : 102.02 (-0.91%)
UniQure: Q1 Earnings Snapshot

UniQure: Q1 Earnings Snapshot

QURE : 5.65 (+4.24%)

Business Summary

UNIQURE B.V. is involved in developing gene therapy for patients of genetic or acquired diseases. It offers Glybera for the treatment of lipoprotein lipase deficiency, an orphan metabolic disease. The company's product pipeline includes which are in clinical trials are additional adeno-associated virus...

See More

Key Turning Points

3rd Resistance Point 6.23
2nd Resistance Point 5.94
1st Resistance Point 5.80
Last Price 5.65
1st Support Level 5.37
2nd Support Level 5.08
3rd Support Level 4.94

See More

52-Week High 11.35
Fibonacci 61.8% 8.44
Fibonacci 50% 7.54
Fibonacci 38.2% 6.64
Last Price 5.65
52-Week Low 3.73

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar